Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients
Annalisa Adamo(University of Verona), Stefano Ugel(University of Verona)
Cited by 12
Related Papers
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
|Journal of Clinical Investigation|2015|554
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3
|Journal for ImmunoTherapy of Cancer|2019|187
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy
|Oncotarget|2017|29
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis
|Cell Death and Differentiation|2021|22